Literature DB >> 12446394

Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil.

J B Jonas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12446394      PMCID： PMC1771409          DOI： 10.1136/bjo.86.12.1450-a

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.

Authors:  R P Danis; T A Ciulla; L M Pratt; W Anliker
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye.

Authors:  R Machemer
Journal:  Retina       Date:  1996       Impact factor: 4.256

3.  Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy.

Authors:  J B Jonas; J K Hayler; A Söfker; S Panda-Jonas
Journal:  Am J Ophthalmol       Date:  2001-04       Impact factor: 5.258

4.  Treatment of intraocular proliferations with intravitreal steroids.

Authors:  R Machemer; G Sugita; Y Tano
Journal:  Trans Am Ophthalmol Soc       Date:  1979

5.  Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Authors:  J K Challa; M C Gillies; P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1998-11
  5 in total
  8 in total

1.  Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

2.  Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities.

Authors:  Ankur M Shah; Stephen F Oster; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

3.  The problem of pressure elevation associated with intravitreal triamcinolone.

Authors:  M D Conway
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

4.  Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.

Authors:  B R Kosobucki; W R Freeman; L Cheng
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

5.  Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors.

Authors:  Ziad F Bashshur; Abdallah M Terro; Christelle P El Haibi; Akaber M Halawi; Alexandre Schakal; Baha' N Noureddin
Journal:  Clin Ophthalmol       Date:  2008-06

Review 6.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

7.  Distribution of Triamcinolone Acetonide after Intravitreal Injection into Silicone Oil-Filled Eye.

Authors:  Ma Da; Kenneth K W Li; Kevin C Chan; Ed X Wu; David S H Wong
Journal:  Biomed Res Int       Date:  2016-07-14       Impact factor: 3.411

Review 8.  Preoperative, Intraoperative and Postoperative Corticosteroid Use as an Adjunctive Treatment for Rhegmatogenous Retinal Detachment.

Authors:  Vincenza Bonfiglio; Michele Reibaldi; Iacopo Macchi; Matteo Fallico; Corrado Pizzo; Clara Patane; Andrea Russo; Antonio Longo; Alessandra Pizzo; Giovanni Cillino; Salvatore Cillino; Maria Vadalà; Michele Rinaldi; Robert Rejdak; Katarzyna Nowomiejska; Mario Damiano Toro; Teresio Avitabile; Elina Ortisi
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.